MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Magnesium Sulfate In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?
Magnesium Sulfate In Dextrose 5% In Plastic Container is a drug marketed by B Braun Medical, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, and Pharmobedient. and is included in six NDAs.
The generic ingredient in MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER is magnesium sulfate. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Magnesium Sulfate In Dextrose 5% In Plastic Container
A generic version of MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 402 |
| DailyMed Link: | MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Queen Savang Vadhana Memorial Hospital, Thailand | NA |
| Hennepin Healthcare Research Institute | PHASE1 |
| Nebraska Methodist Health System | PHASE3 |
See all MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
Pharmacology for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents and Regulatory Information for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun Medical | MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207966-001 | Oct 27, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209932-001 | Sep 10, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hospira | MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020488-001 | Jul 11, 1995 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
